Technology
Health
Biotechnology

Autolus Therapeutics

$24.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.20%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AUTL and other stocks, options, ETFs, and crypto commission-free!

About

Autolus Therapeutics plc American Depositary Share, also called Autolus Therapeutics, is a biopharmaceutical company. It engages in the development of cancer treatments. Read More The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom.

Employees
166
Headquarters
London, Greater London
Founded
2018
Market Cap
991.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
90.51K
High Today
$25.98
Low Today
$24.50
Open Price
$24.96
Volume
7.55K
52 Week High
$53.24
52 Week Low
$19.17

Collections

Technology
Health
Biotechnology
Cancer Prevention
Therapy
Biopharmaceutical
Pharmaceutical
2018 IPO

Earnings

-$0.62
-$0.59
-$0.55
-$0.52
Q1 2018
Q2 2018
Q3 2018
Estimated
—
Actual
Expected May 15, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.